$1.99
0.052.58%
Pre-Market: Mar 28, 9:28 AM EDT
Comments
Loading...
Innate Pharma Earnings Estimates, EPS & Revenue | NASDAQ:IPHA | Benzinga
Innate Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 27
EPS
$-0.651
Quarterly Revenue
$21.48M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$24.85M
Analyze the earnings history of Innate Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPHA | Innate Pharma | -$0.10 | — | -$0.65 | — | $66.35M | — | $21.48M | — | 03/27/2025 | Get Alert |
| IPHA | Innate Pharma | $0.02 | — | -$0.34 | — | $43.48M | — | $13.35M | — | 09/12/2024 | Get Alert |
| IPHA | Innate Pharma | -$0.75 | — | -$0.10 | — | $58.87M | — | $66.35M | — | 03/21/2024 | Get Alert |
| IPHA | Innate Pharma | $0.09 | — | $0.02 | — | $49.88M | — | $43.48M | — | 09/14/2023 | Get Alert |
| IPHA | Innate Pharma | -$0.65 | — | -$0.75 | — | $28.25M | — | $58.87M | — | 03/23/2023 | Get Alert |
| IPHA | Innate Pharma | -$0.36 | — | $0.09 | — | $18.91M | — | $49.88M | — | 09/15/2022 | Get Alert |
| IPHA | Innate Pharma | — | — | -$0.65 | — | — | — | $28.25M | — | 03/24/2022 | Get Alert |
| IPHA | Innate Pharma | — | — | -$0.36 | — | — | — | $18.91M | — | 09/15/2021 | Get Alert |
Innate Pharma (IPHA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Innate Pharma (IPHA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Innate Pharma (NASDAQ:IPHA) reporting earnings?
Innate Pharma (IPHA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 27, 2025 for FY.
What were the latest earnings per share (EPS) for Innate Pharma (NASDAQ:IPHA)?
Innate Pharma (IPHA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 27, 2025 for FY and the Actual EPS was $-0.65, which missed the estimate of $0.00.
What were Innate Pharma’s (NASDAQ:IPHA) revenues?
Innate Pharma (IPHA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 27, 2025 for FY and the Actual Revenue was $21.5M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.